Literature DB >> 2463516

Preferred sites of recombination in poliovirus RNA: an analysis of 40 intertypic cross-over sequences.

A M King1.   

Abstract

The genome of poliovirus consists of a single strand of RNA approximately 7.5 kb long. Analysis of the sequences around 40 unique recombination sites reveals several features that differ significantly from those expected of randomly located sites. These features, which include a broad zone of elevated homology on the 3' side of the cross-over, support the theory that RNA recombination occurs by a template-switching mechanism during synthesis of the complementary strand, and that sites are chosen to minimise the adverse free energy change involved in switching to a heterotypic template. There is also a strong sequence bias, almost two-thirds of cross-overs, according to a computer simulation, occurring immediately after synthesis of UU. These features shed new light on the extent of base-pairing in replicative intermediate RNA, and on the mechanism of chain initiation.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2463516      PMCID: PMC339105          DOI: 10.1093/nar/16.24.11705

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  26 in total

1.  Globin mRNA sequences: analysis of base pairing and evolutionary implications.

Authors:  W Salser
Journal:  Cold Spring Harb Symp Quant Biol       Date:  1978

2.  A genetic map of poliovirus temperature-sensitive mutants.

Authors:  P D Cooper
Journal:  Virology       Date:  1968-08       Impact factor: 3.616

3.  Complete nucleotide sequences of all three poliovirus serotype genomes. Implication for genetic relationship, gene function and antigenic determinants.

Authors:  H Toyoda; M Kohara; Y Kataoka; T Suganuma; T Omata; N Imura; A Nomoto
Journal:  J Mol Biol       Date:  1984-04-25       Impact factor: 5.469

4.  Structure of poliovirus replicative intermediate RNA. Electron microscope analysis of RNA cross-linked in vivo with psoralen derivative.

Authors:  O C Richards; S C Martin; H G Jense; E Ehrenfeld
Journal:  J Mol Biol       Date:  1984-03-05       Impact factor: 5.469

5.  Primary structure, gene organization and polypeptide expression of poliovirus RNA.

Authors:  N Kitamura; B L Semler; P G Rothberg; G R Larsen; C J Adler; A J Dorner; E A Emini; R Hanecak; J J Lee; S van der Werf; C W Anderson; E Wimmer
Journal:  Nature       Date:  1981-06-18       Impact factor: 49.962

6.  The nucleotide sequence of poliovirus type 3 leon 12 a1b: comparison with poliovirus type 1.

Authors:  G Stanway; A J Cann; R Hauptmann; P Hughes; L D Clarke; R C Mountford; P D Minor; G C Schild; J W Almond
Journal:  Nucleic Acids Res       Date:  1983-08-25       Impact factor: 16.971

7.  Poliovirus replicase stimulation by terminal uridylyl transferase.

Authors:  N C Andrews; D Levin; D Baltimore
Journal:  J Biol Chem       Date:  1985-06-25       Impact factor: 5.157

8.  Mapping of sequences required for mouse neurovirulence of poliovirus type 2 Lansing.

Authors:  N La Monica; C Meriam; V R Racaniello
Journal:  J Virol       Date:  1986-02       Impact factor: 5.103

9.  Comparison of the complete nucleotide sequences of the genomes of the neurovirulent poliovirus P3/Leon/37 and its attenuated Sabin vaccine derivative P3/Leon 12a1b.

Authors:  G Stanway; P J Hughes; R C Mountford; P Reeve; P D Minor; G C Schild; J W Almond
Journal:  Proc Natl Acad Sci U S A       Date:  1984-03       Impact factor: 11.205

10.  Complete nucleotide sequence of the attenuated poliovirus Sabin 1 strain genome.

Authors:  A Nomoto; T Omata; H Toyoda; S Kuge; H Horie; Y Kataoka; Y Genba; Y Nakano; N Imura
Journal:  Proc Natl Acad Sci U S A       Date:  1982-10       Impact factor: 11.205

View more
  34 in total

1.  Recombination of poliovirus RNA proceeds in mixed replication complexes originating from distinct replication start sites.

Authors:  Denise Egger; Kurt Bienz
Journal:  J Virol       Date:  2002-11       Impact factor: 5.103

2.  Evolution of the Sabin strain of type 3 poliovirus in an immunodeficient patient during the entire 637-day period of virus excretion.

Authors:  J Martín; G Dunn; R Hull; V Patel; P D Minor
Journal:  J Virol       Date:  2000-04       Impact factor: 5.103

3.  Efficient in vitro system of homologous recombination in brome mosaic bromovirus.

Authors:  Rafal Wierzchoslawski; Jozef J Bujarski
Journal:  J Virol       Date:  2006-06       Impact factor: 5.103

Review 4.  The polymerase in its labyrinth: mechanisms and implications of RNA recombination.

Authors:  T C Jarvis; K Kirkegaard
Journal:  Trends Genet       Date:  1991-06       Impact factor: 11.639

5.  Nonhomologous RNA recombination during negative-strand synthesis of flock house virus RNA.

Authors:  Y Li; L A Ball
Journal:  J Virol       Date:  1993-07       Impact factor: 5.103

6.  Template-switching during DNA synthesis by Thermus aquaticus DNA polymerase I.

Authors:  S J Odelberg; R B Weiss; A Hata; R White
Journal:  Nucleic Acids Res       Date:  1995-06-11       Impact factor: 16.971

7.  Group-specific identification of polioviruses by PCR using primers containing mixed-base or deoxyinosine residue at positions of codon degeneracy.

Authors:  D R Kilpatrick; B Nottay; C F Yang; S J Yang; M N Mulders; B P Holloway; M A Pallansch; O M Kew
Journal:  J Clin Microbiol       Date:  1996-12       Impact factor: 5.948

8.  Serial recombination during circulation of type 1 wild-vaccine recombinant polioviruses in China.

Authors:  Hong-Mei Liu; Du-Ping Zheng; Li-Bi Zhang; M Steven Oberste; Olen M Kew; Mark A Pallansch
Journal:  J Virol       Date:  2003-10       Impact factor: 5.103

9.  A model for rearrangements in RNA genomes.

Authors:  E V Pilipenko; A P Gmyl; V I Agol
Journal:  Nucleic Acids Res       Date:  1995-06-11       Impact factor: 16.971

10.  Identification of vaccine-related polioviruses by hybridization with specific RNA probes.

Authors:  L De; B Nottay; C F Yang; B P Holloway; M Pallansch; O Kew
Journal:  J Clin Microbiol       Date:  1995-03       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.